Munich, Germany

Walter Goblmeier

This inventor holds 1 USPTO granted patent. Top assignee: Wacker-Chemie Gmbh. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Walter Goblmeier: Innovator in Elastomer Technology

Introduction

Walter Goblmeier is a notable inventor based in Munich, Germany. He has made significant contributions to the field of elastomer technology, particularly through his innovative patent. His work focuses on creating compositions that enhance the properties of elastomers, making them more effective for various applications.

Latest Patents

Walter Goblmeier holds a patent for "Organopolysiloxane compositions which cross-link to give elastomers." This invention provides compositions based on diorganopolysiloxanes that crosslink to produce elastomers without toxic curing catalysts, such as tin catalysts. The resulting elastomers exhibit high tensile strength and are suitable for use as coatings, showcasing their versatility and safety.

Career Highlights

Walter Goblmeier is associated with Wacker-Chemie GmbH, a leading company in the chemical industry. His work at Wacker-Chemie has allowed him to develop and refine his innovative ideas, contributing to the company's reputation for excellence in chemical solutions.

Collaborations

Walter has collaborated with notable coworkers, including Ekkehard Patrick and Herbert Eck. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies in elastomer applications.

Conclusion

Walter Goblmeier's contributions to elastomer technology through his innovative patent demonstrate his commitment to advancing the field. His work not only enhances the properties of elastomers but also prioritizes safety and effectiveness in their applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…